Together, these studies highlight the diverse roles of ADAM12 in cancer progression, ranging from its involvement in angiogenesis, metastasis, and therapy resistance to its potential as a prognostic biomarker, thereby warranting further investigation into its clinical relevance across tumour types. Here, ADAM12 is linked to neoplasm.